{"entity":{"id":"andres-cervantes","kind":"person","name":"Andrés Cervantes","aka":[],"tldr":"Andrés Cervantes is a gastrointestinal oncologist and was ESMO President for 2023-2024.","summary":"Andrés Cervantes is Professor of Medicine at the University of Valencia and Head of Medical Oncology at the INCLIVA Biomedical Research Institute and Hospital Clínico Universitario de Valencia, and served as President of the European Society for Medical Oncology (ESMO) for 2023-2024. A gastrointestinal oncologist specialising in colorectal cancer, he is best known for guideline work. He led the ESMO Clinical Practice Guidelines on metastatic colorectal cancer in Annals of Oncology, in their 2014 and 2023 editions, and co-authored the 2012 ESMO consensus guidelines on a personalised approach to colon and rectal cancer. His publications are listed on PubMed.","asOf":"2026-09-08","links":[{"label":"PubMed","url":"https://pubmed.ncbi.nlm.nih.gov/?term=Cervantes%20A%5BAuthor%5D%20colorectal"}],"tags":[],"related":[],"cancers":["colorectal"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":["esmo","incliva-valencia"],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"role":"Professor of Medicine, University of Valencia; Head of Medical Oncology, INCLIVA; ESMO President 2023-2024","institutionId":"esmo","specialisms":["Gastrointestinal oncology","Colorectal cancer","Guidelines"],"profiles":[{"label":"PubMed","url":"https://pubmed.ncbi.nlm.nih.gov/?term=Cervantes%20A%5BAuthor%5D%20colorectal"}],"papers":[{"title":"Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up","journal":"Annals of Oncology","year":2023,"doi":"10.1016/j.annonc.2022.10.003"},{"title":"ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making","journal":"Annals of Oncology","year":2012,"doi":"10.1093/annonc/mds236"},{"title":"Metastatic colorectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","journal":"Annals of Oncology","year":2014,"doi":"10.1093/annonc/mdu260"}]},"route":"/people/andres-cervantes/","neighbours":{"cancer":[{"id":"colorectal","kind":"cancer","name":"Colorectal cancer","route":"/cancers/colorectal/"}],"institution":[{"id":"esmo","kind":"institution","name":"European Society for Medical Oncology (ESMO)","route":"/institutions/esmo/"},{"id":"incliva-valencia","kind":"institution","name":"INCLIVA Biomedical Research Institute / Hospital Clínico Universitario de Valencia","route":"/institutions/incliva-valencia/"}],"paper":[{"id":"paper-esmo-metastatic-colorectal-cancer-guideline-ann-oncol-2023","kind":"paper","name":"Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up","route":"/key-papers/paper-esmo-metastatic-colorectal-cancer-guideline-ann-oncol-2023/"},{"id":"paper-arnold-primary-tumour-side-ras-wild-type-ann-oncol-2017","kind":"paper","name":"Prognostic and predictive value of primary tumour side in patients with RAS wild-type metastatic colorectal cancer treated with chemotherapy and EGFR directed antibodies in six randomized trials","route":"/key-papers/paper-arnold-primary-tumour-side-ras-wild-type-ann-oncol-2017/"},{"id":"paper-esmo-rectal-cancer-guideline-ann-oncol-2017","kind":"paper","name":"Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","route":"/key-papers/paper-esmo-rectal-cancer-guideline-ann-oncol-2017/"}]}}